Fig. 1From: Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6Isolation and identification of BMSCs. The BMSCs samples were isolated from the bone marrow of 12 cases of MM patients and 10 cases of BD patients. A, B Surface markers of bone marrow-derived mesenchymal stem cells isolated from A BD patients (BD-BMSCs) or B MM patients (MM-BMSCs) were examined by flow cytometry. C BD-BMSCs and MM-BMSCs were used for osteogenic differentiation induction, and the Alizarin red staining was performed to assess osteogenesis. D After lipogenic differentiation for 21Â days, Oil red O staining determined the adipose differentiation abilityBack to article page